Progress of hepatitis B virus-associated intrahepatic cholangiocarcinoma
10.3760/cma.j.cn115355-20230328-00157
- VernacularTitle:乙型肝炎病毒相关肝内胆管细胞癌的研究进展
- Author:
Tianfu LIU
1
;
Guangming LI
;
Lingyi ZHANG
Author Information
1. 兰州大学第二医院肝病科，兰州 730030
- Keywords:
Hepatitis B virus;
Intrahepatic cholangiocarcinoma;
Infection;
Treatment
- From:
Cancer Research and Clinic
2024;36(7):546-549
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma (ICC) is characterized with low incidence, high malignancy and poor prognosis. In China, hepatitis B virus (HBV)-associated ICC is the most common subtype of ICC and its incidence rate is on the rise. The pathogenesis and clinical characteristics of HBV-associated ICC are different from other types of ICC. In recent years, the targeted therapy has brought significant survival benefits for patients. This article reviews the pathogenesis of HBV-associated ICC and the latest research progress of the clinical characteristics and treatments of patients.
